首页> 美国卫生研究院文献>Aging (Albany NY) >Exosomal miRNA-34 from cancer-associated fibroblasts inhibits growth and invasion of gastric cancer cells in vitro and in vivo
【2h】

Exosomal miRNA-34 from cancer-associated fibroblasts inhibits growth and invasion of gastric cancer cells in vitro and in vivo

机译:来自癌症相关成纤维细胞的外泌体miRNA-34在体外和体内抑制胃癌细胞的生长和侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gastric cancer (GC) is one of the most common malignancies worldwide manifesting high morbidity and mortality. Cancer-associated fibroblasts (CAFs), important components of the tumor microenvironment, are essential for tumorigenesis and progression. Exosomes secreted from CAFs have been reported as the critical molecule-vehicle in intercellular crosstalk. However, the precise mechanism underlying the effect of CAFs remains to be fully investigated. In this study, we aimed to determine the role of CAFs and their exosomes in the progression of GC and related mechanisms. The results revealed that miRNA-34 was downregulated in both GC fibroblasts (GCFs) and GC cell lines while the overexpression of miRNA-34 suppressed the proliferation, invasion, and motility of GC cell lines. Coculturing GC cells with miRNA-34-overexpressing GCFs led to the suppression of cancer progression. Also, exosomes derived from GCFs were taken up by GC cells and and exerted antitumor roles in GC. In addition, exosomal miRNA-34 inhibited GC cell proliferation and invasion and suppressed tumor growth . Furthermore, 16 genes were identified as potential downstream targeting genes of miRNA-34. Taken together, GCFs-derived exosomal miRNA-34 may be a promising targeting molecule for therapeutic strategies in GC.
机译:胃癌(GC)是世界范围内最常见的恶性肿瘤之一,表现出较高的发病率和死亡率。肿瘤相关成纤维细胞(CAF)是肿瘤微环境的重要组成部分,对于肿瘤的发生和发展至关重要。据报道,CAF分泌的外来体是细胞间串扰中的关键分子载体。但是,CAF作用的确切机制尚待充分研究。在这项研究中,我们旨在确定CAF及其外泌体在GC进展及相关机制中的作用。结果表明,miRNA-34在GC成纤维细胞(GCF)和GC细胞系中均被下调,而miRNA-34的过表达抑制了GC细胞系的增殖,侵袭和运动。将GC细胞与过表达miRNA-34的GCF共同培养可抑制癌症进展。此外,GC细胞吸收了来自GCF的外泌体,并在GC中发挥抗肿瘤作用。另外,外泌体miRNA-34抑制GC细胞增殖和侵袭并抑制肿瘤生长。此外,确定了16个基因作为miRNA-34的潜在下游靶向基因。综上所述,源自GCFs的外泌体miRNA-34可能是有前途的靶向分子,用于GC治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号